GSK126 |
|
| Synonyms: (S)-1-(sec-butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide; GSK-126 | |
| Cat. No.: G98000 | CAS No.: 1346574-57-9 |
| MDL.: | Formula: C31H38N6O2 |
| F.W.526.67 | Purity: 99% |
| Storage: | |
|   | |
| Catalog Number: | G98000 | CAS No.: | 1346574-57-9 | |
| MDL: | Formula: | C31H38N6O2 | ||
| F.W.: | 526.67 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | M.P.: | |||
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | DMSO | Stability: | ||
| Storage: | Category: | Reference Standard | ||
| Application: | GSK126 is a potent, highly selective, S-adenosyl-methionine-competitive, small-molecule inhibitor of EZH2 methyltransferase activity, decreases global H3K27me3 levels and reactivates silenced PRC2 target genes. | |||








